Biotech Values

[DewDiligence]

>I thought that Sam Waksal pushed (working tirelessly to raise funding) the drug through when few, if any others, believed in the MoA or utility of the drug.<

That’s true; however, a substantial portion of Waksal’s heroics occurred before ImClone’s IPO.

>If I have that right, he does not belong on the list of worst CEO's despite his illegal attempt to take advantage of the FDA setback.<

I’ll refine the survey so it pertains only to the period in which the individuals in question were the CEO of a publicly-traded company.